Cytomegalovirus human immunoglobulin intravenous (Shandong Taibang Biological Products)
巨细胞病毒人免疫球蛋白(pH4) (山东泰邦生物制品)
Report date: 2026/05/27 16:53:31
Base Information
Drug NameCytomegalovirus human immunoglobulin intravenous (Shandong Taibang Biological Products)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusN/A
Highest Status in ChinaN/A
Originator CompaniesShandong Taibang Biological Products Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A